Edesa Biotech, Inc.
EDSA
$1.45
-$0.03-2.03%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 29.02% | -16.45% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 29.76% | 16.16% | |||
| Operating Income | -29.76% | -16.16% | |||
| Income Before Tax | -27.37% | -10.06% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -27.37% | -10.00% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -27.37% | -10.00% | |||
| EBIT | -29.76% | -16.16% | |||
| EBITDA | -30.16% | -16.33% | |||
| EPS Basic | -26.82% | 16.91% | |||
| Normalized Basic EPS | -27.50% | 11.07% | |||
| EPS Diluted | -26.82% | 16.91% | |||
| Normalized Diluted EPS | -27.50% | 11.07% | |||
| Average Basic Shares Outstanding | 0.46% | 32.36% | |||
| Average Diluted Shares Outstanding | 0.46% | 32.36% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||